These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 153620)

  • 21. Kinetics and specificity of the secondary MLR and CML.
    Dausset J
    Transplant Proc; 1976 Sep; 8(3):441-7. PubMed ID: 62434
    [No Abstract]   [Full Text] [Related]  

  • 22. [Determination of histocompatibility using cell-mediated lympholysis].
    Potmĕsilová I; Soucek J; Novák JT
    Vnitr Lek; 1980 Nov; 26(11):1072-8. PubMed ID: 6455007
    [No Abstract]   [Full Text] [Related]  

  • 23. Cytotoxic T cell activity after HLA-mismatch bone marrow transplantation.
    Møller J; Dickmeiss E; Jacobsen N; Svejgaard A
    Tokai J Exp Clin Med; 1996 Feb; 21(1):19-23. PubMed ID: 9239800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular basis of defective cell-mediated lympholysis in atopic dermatitis.
    Leung DY; Wood N; Dubey D; Rhodes AR; Geha RS
    J Immunol; 1983 Apr; 130(4):1678-82. PubMed ID: 6220063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is cell-mediated immunity in the uremic patient affected by blood transfusion?
    Fehrman I; Ringdén O; Möller E; Lundgren G; Groth CG
    Transplant Proc; 1981 Mar; 13(1 Pt 1):164-6. PubMed ID: 6455789
    [No Abstract]   [Full Text] [Related]  

  • 26. Identification of human CML target. HLA-B locus (B12) antigen variants defined by CTL generated between B locus-identical (B12) responder-stimulator pairs.
    Kato S; Iványi P; Lacko E; Breur B; Du Bois R; Eijsvoogel VP
    J Immunol; 1982 Feb; 128(2):949-55. PubMed ID: 6976390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA-restricted cell-mediated cytotoxicity directed against male specific (H-Y) antigen after acute rejection of an HLA-identical sibling kidney.
    Pfeffer PF; Sødal G; Thorsby E
    Scand J Urol Nephrol Suppl; 1981; 64():72-8. PubMed ID: 6216585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional cell mediated lympholysis: II. Genetics.
    Goeken NE; Thompson JS
    Tissue Antigens; 1981; 17(4):411-20. PubMed ID: 6949337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation by antiidiotypic monoclonal antibodies of immune lysis mediated by anti-HLA monoclonal antibodies.
    Ono R; Sakaguchi K; Ferrone S
    J Immunol; 1989 Sep; 143(6):1921-9. PubMed ID: 2528584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normal hematopoietic progenitor cells and malignant lymphohematopoietic cells show different susceptibility to direct cell-mediated MHC-non-restricted lysis by T cell receptor-/CD3-, T cell receptor gamma delta+/CD3+ and T cell receptor-alpha beta+/CD3+ lymphocytes.
    Voogt PJ; Falkenburg JH; Fibbe WE; Veenhof WF; Hamilton M; Van Krimpen BA; Bolhuis RL
    J Immunol; 1989 Mar; 142(5):1774-80. PubMed ID: 2521886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigenicity of HLA-D locus antigens in human cell-mediated lympholysis.
    Ohsawa N; Akiyama N
    Jpn J Exp Med; 1983 Feb; 53(1):65-8. PubMed ID: 6308312
    [No Abstract]   [Full Text] [Related]  

  • 32. Maternal cell-mediated immunity in pregnancy--lymphocyte responses of mothers and their non-pregnant HLA identical sisters to paternal HLA.
    Moore MP; Sargent IL; Ting A; Redman CW
    Clin Exp Immunol; 1983 Oct; 54(1):91-4. PubMed ID: 6225586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Autologous mixed lymphocyte culture (AMLC)].
    Volk HD; Grunow R
    Allerg Immunol (Leipz); 1984; 30(2):60-73. PubMed ID: 6237558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of memory CD4+, CD8+, CD45RO+ and CD16- lymphocytes activated with IL-2, INF-gamma, and TNF-alpha with specific cytotoxicity against autologous cervical cancer cells in a mixed leukocyte-tumour cell culture.
    Rangel R; Rocha L; Ramirez JL; Ibarra MJ; Solorza G; Monroy A; Ramirez MA; Herrera A; Weiss-Steider B
    Eur Cytokine Netw; 1995; 6(3):195-202. PubMed ID: 8589277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Target antigens of cell-mediated lympholysis discrimination of HLA subtypes by cytotoxic lymphocytes.
    Robinson MA; Noreen HJ; Amos DB; Yunis EJ
    J Immunol; 1978 Oct; 121(4):1486-90. PubMed ID: 701804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histocompatibility and natural cell-mediated cytotoxicity.
    Takasugi M; Koide Y; Takasugi J; Akira D; Opelz G
    Transplant Proc; 1979 Jun; 11(2):1332-3. PubMed ID: 157571
    [No Abstract]   [Full Text] [Related]  

  • 37. [HLA and lymphocyte physiology].
    Lebrun A
    Union Med Can; 1981 Apr; 110(4):303-12. PubMed ID: 6454297
    [No Abstract]   [Full Text] [Related]  

  • 38. Involvement of HLA in T-cell immune responses.
    Thorsby E; Bergholtz B; Berle E; Braathen L; Hirschberg H
    Transplant Proc; 1981 Mar; 13(1 Pt 2):903-8. PubMed ID: 6455828
    [No Abstract]   [Full Text] [Related]  

  • 39. Surface IgG-mediated mixed lymphocyte culture and cell-mediated lympholysis responses by immunocompetent thymus cells.
    Dyminski JW
    Thymus; 1981 Nov; 3(4-5):257-75. PubMed ID: 6458934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term culture, cloning, and surface markers of mixed leukocyte culture-derived human T lymphocytes with natural killer-like cytotoxicity.
    Pawelec GP; Hadam MR; Ziegler A; Lohmeyer J; Rehbein A; Kumbier I; Wernet P
    J Immunol; 1982 Apr; 128(4):1892-6. PubMed ID: 6460813
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.